Podcast: Play in new window | Download (Duration: 23:02 — 10.5MB) | Embed
On this episode of the Top 200 drugs podcast from Real Life Pharmacology, I cover medications 131-135 which include enoxaparin, methylphenidate, rosuvastatin, denosumab, and dabigatran.
Enoxaparin is an injectable anticoagulant that can cause heparin-induced thrombocytopenia.
Methylphenidate is a stimulant medication that can be used to treat ADHD. Cardiovascular adverse effects are possible.
Rosuvastatin inhibits HMG-CoA Reductase which helps lower LDL in the management of hypercholesterolemia.
Denosumab is a monoclonal antibody that is indicated for osteoporosis and may cause hypocalcemia.
Dabigatran was one of the first direct oral anticoagulants to be produced. It is dosed twice daily and has warnings about use in patients over the age of 75.
Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!
Support The Podcast and Check Out These Amazing Resources!
Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)
Guide to Drug Food Interactions (Amazon Best Seller)
